TMA-2
2,4,5-trimethoxyamphetamine
1Provenance card
the boundary, as counts
Sources
1810 with DOI
0 strong · 14 moderate · 4 weak
Compilations
12026-04-26T20:56:07.989Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
31last ruled 2026-06-04
0 awaiting a ruling
Issued documents
52026-10-19T20:34:20.975Z
notice · info card · emergency
Searches
151 with no results
queries and counts on the build
Claims checked
4728 supported
28 supported · 19 not
Correspondence
0received
consent field ships in Phase 4
Edges
173
derivations recorded for this entity
Complete over 18 sources, 1 compilation, and 31 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/tma-2/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued emergency
- 2026-10-19issueIssued info_card
- 2026-09-24srcSerotonin toxicity of serotonergic psychedelics
- 2026-09-24srcAnalysis of 2,5-dimethoxy-amphetamines and 2,5-dimethoxy-phenethylamines aiming their determination in biological matrices: a review.
- 2026-09-24srcLC-MS analysis of trimethoxyamphetamine designer drugs (TMA series) from urine samples
- 2026-09-24srcRole of the 5-HT2A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice
- 2026-09-24src2,5-Dimethoxyamphetamine-derived designer drugs: studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6.
- 2026-09-24srcInvestigation of the 2,5-Dimethoxy Motif in Phenethylamine Serotonin 2A Receptor Agonists
- 2026-09-24srcTolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice
- 2026-09-24srcELISA Detection of 30 New Amphetamine Designer Drugs in Whole Blood, Urine and Oral Fluid using Neogen Amphetamine and Methamphetamine/MDMA Kits
- 2026-09-24srcComparison of the behavioral effects of mescaline analogs using the head twitch response in mice
- 2026-09-24srcReceptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines.
- 2026-09-24srcMechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor
- 2026-09-24srcDesigner drug 2,4,5-trimethoxyamphetamine (TMA-2): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques
- 2026-09-24srcThe effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.
- 2026-09-24srcComparison of behavioral properties of di- and tri-methoxyphenylisopropylamines
- 2026-09-24srcCouncil Decision 2003/847/JHA concerning control measures and criminal sanctions in respect of the new synthetic drugs 2C-I, 2C-T-2, 2C-T-7 and TMA-2
- 2026-09-24src2,4,5-Trimethoxyamphetamine (TMA-2) product listing
- 2026-09-24src2,4,5-Trimethoxyamphetamine chemical data (NCATS Inxight Drugs)
- 2026-09-24srcReport on the risk assessment of TMA-2 (EMCDDA, 2003)
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-06-04proposal29 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-04-26revisionRevision 1
- 2026-04-26absenceSearched ClinicalTrials.gov for "TMA-2 trimethoxyamphetamine" — no results
- 2026-04-26genGeneration — pipeline-v5pipeline-v5
- 2026-04-26rungeneration run
The same entries, as forms: six forms.